Cholestenoic acid is a prognostic biomarker in acute respiratory distress syndrome

Lower plasma levels of the oxysterol cholestenoic acid associate with increased mortality and organ failure in septic patients with acute respiratory distress syndrome (ARDS). Cholestenoic acid warrants further validation as a novel ARDS biomarker.